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ofMore Rapid Screening Tests
SYNOPSIS
NEW RAPID HUMAN immunodeficiency virus (HIV) antibody tests permit
many individuals to receive test results and appropriate counseling at one clinic
visit. Because currently used tests require significant time for processing, all indi-
viduals must return for a second visit for test results and counseling. Since return
rates for the second visit are low, the more rapid tests present an opportunity to
improve the efficiency of HIV counseling and testing.
The authors compared the costs and effectiveness of the currently used
counseling and testing procedure and a streamlined procedure made possible by
the new, more rapid screening tests. When test-positive clients are given prelim-
inary screening test results, the rapid procedure is more cost-effective than the
current procedure. Since over 90% of the clients in most clinics will test negative,
the rapid counseling and testing procedure allows the vast majority of clients to
be counseled and tested and to receive their results and posttest counseling in
one visit. However, in the case where the goal of HIV counseling and testing is to
focus only on infected individuals, if information regarding a positive result from
the rapid screening test is not given to clients at the initial visit before a confirma-
tory test is performed, then the rapid counseling and testing procedure is not
more cost-effective than the current procedure.
Tearsheet requests to Paul G. Farnham,
PhD, Department ofEconomics, Georgia
State University, Atlanta, GA 30303; tel.
404-651-2624;fax 404-651-3996;
e-mail <eco.pgftlangate.gsu.edu>.
Cn ounseling and testing (C/T) for human immunodeficiency virus
antibodies has been a major component of U.S. HIV prevention
and care strategies. In 1991, more than two million HIV anti-
body tests were performed at publicly funded sites, of which
approximately 58,000 (2.8%) were positive. Nearly two-thirds
both of reported tests and positive test results occurred at freestanding HIV-
C/T sites and sexually transmitted disease (STD) clinics'.
At least two complex public policy questions concerning HIV CiT have
evolved: When and what types of test information and counseling should clients
receive? and should the purpose ofHIV C/T be to focus only on HIV-infected
individuals for prevention and health care services or to inform and counsel both
infected and uninfected individuals about the implications of their test results?
Under the current procedures, HIV counseling and testing includes the fol-
lowing steps (Table 1): Step 1. The client is offered counseling and testing. Step
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Table 1. Components of counseling and testing (C/T) procedures
Current CUT
Component HIV-
1. Administrative processing/offer of C/T........................
2. Pretest counseling .............................................................
3. Draw blood.........................................................................
4. Transport to laboratory...................................................
5. Screening and confirmatory testing:
Initial ELISA test.................................................................
Followup ELISA tests, n=2..............................................
Initial rapid test..................................................................
Followup rapid test, n= I .................................................
Western blot test..............................................................
6. Test results/posttest counseling:
Waiting time- initial visit ................................................
Posttest counseling, initial visit.......................................
Time for return..................................................................
Administrative processing, return visit.........................
Posttest counseling, return visit.....................................
x
x
x
x
...x
...
x
x
X
2. Clients who accept are counseled prior to testing (pretest
counseling). Step 3. A blood sample is drawn from the
client. Step 4. The sample is transported to a laboratory,
which may be either on- or off-site. Step 5. The serum is
tested for HIV antibody using a screening test. If this result
is negative, there is no further testing. If the test is positive,
screening tests are repeated using
the same specimen. Positive
results on the repeated screening
tests require a follow-up confir-
matory test. Step 6. Test results
are given to the clinician/coun-
selor, who informs and counsels
the client (posttest counseling).
Recently developed rapid
HIV-antibody screening tests
allow changes in Steps 4 through
6, eliminating time lags. The cur-
rent counseling and testing procedure generally relies on the
enzyme-linked immunosorbent assay (ELISA), designed for
batch testing, as the initial screening test2. The average time
for accumulating and running an ELISA batch is two to
three hours. Low-volume laboratories may transport speci-
mens to a higher volume laboratory to reach the optimum
batch size, further increasing the time from Step 4 to Step 5.
The most widely used confirmatory test, the Western blot,
may not be performed every day in most laboratories. There-
fore, under the current procedure, test results are not avail-
able during the client's first visit, thus requiring a return visit
one to three weeks later to learn test results and receive
posttest counseling.
Alternatively, the rapid HIV screening tests are designed
to be used as a single assay and take 10 minutes or less on
average2. With rapid tests, even a low-volume on-site labo-
S
S
ratory can provide test results at the client's first visit. How-
ever, as in the current C/T procedure, the confirmatory
Western blot test is used for specimens that screen positive,
thus requiring a return visit for these individuals.
Under the current C/T procedure, many clients do not
return for their test results and posttest counseling3. In
1990, only 64% of clients at pub-
licly funded sites returned for test
results and posttest counseling4.
Return rates varied substantially
by type of service delivery site:
42% at STD clinics, 54% at fam-
ily planning clinics, and 58% at
prenatal and obstetric testing
sites.
Tested clients who do not
return for test results and posttest
counseling do not receive the full
benefit of this HIV prevention strategy. Posttest counseling
provides the opportunity to discuss with clients risk behav-
ior and ways of reducing risk, to refer at-risk clients to pre-
vention services, and to refer infected individuals for med-
ical and social services4'5.
Two alternative strategies would increase the proportion
of clients who receive the complete intervention: (a)
increase return rates under the current C/T procedure or (b)
eliminate the need for a return visit for most clients by using
the rapid HIV screening test. The choice of strategies is
influenced by the costs and effectiveness of each approach.
Cost-effectiveness estimates will vary depending on
whether the test site emphasizes the provision of the inter-
vention to all individuals or only to HIV-infected persons.
We present a cost-effectiveness analysis based on a deci-
sion model comparing a streamlined C/T procedure using
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the rapid HIV screening test with the current C/T proce-
dure. We develop disaggregated estimates of the societal
costs of each testing procedure and employ two alternative
outcome measures reflecting possible differences in the
goals of the C/T process.
Methods
We developed a decision model that was based on a
societal perspective and included all costs and effects
incurred by both providers and clients. We incorporated cost
estimates drawn from the
counseling and testing litera-
ture and expert opinion and
imputed values for variables
such as client travel and wait-
ing time. Our model's parame-
ters were based on cost figures
for publicly funded clinics.
We also looked at two
variations from our basic
model. Variation One incor-
porated only the explicit costs
to the providers and excluded
valuations of client time. For
variation Two, we assigned an
alternate outcome value to cases of clients who test positive
with the rapid test and do not return for a confirmatory visit
to analyze the implications of providing information based
on the rapid screening test alone.
Our analysis was developed from the perspective of
adding one or the other testing procedure to an existing
clinic or provider not presently offering HIV C/T. We
assumed that a client would not have
been counseled or tested in the absence
of these procedures. Incremental cost- Figure 1. HIV
effectiveness ratios were calculated
using SMLTREE, version 2.99.
Outcome Measures. We measured two
different outcomes: (a) the number of Tru
HIV-infected individuals who correctly
learn their serostatus and (b) the num-
ber of infected and uninfected individu-
als who correctly learn their serostatus. Current
Both outcomes are important but may tst
receive different emphasis depending
on the clinical setting. Different coun-
seling approaches are used for infected
and uninfected individuals5. Budgetary Tru
constraints and beliefs about the effec-
tiveness of counseling for each group
often determine a clinic's emphasis.
We counted the number of individ-
uals (HIV-infected only or both
infected and uninfected) who would
correctly learn their serostatus under each testing procedure,
assigning each a value of one. We assigned a zero value to
individuals who fail to return to receive their test informa-
tion or who receive incorrect information (false positive or
false negative tests).
Diagnosis ofHIV infection under the current C/T pro-
cedure is based primarily on the Western blot (WB) confir-
matory test, which is done only if the ELISA is positive2.
An initially reactive ELISA test is followed by two subse-
quent ELISA tests and the VVB test to minimize the chance
of a diagnostic error. Therefore, under the current C/T pro-
cedure, individuals must
return in one to three weeks
to learn test results.
With the rapid C/T proce-
dure, a key issue is what infor-
mation and counseling will be
provided to test-positive
55|t"~! | i - clients at the first visit6'7. We
* - assumed that all individuals
will receive test results at the
S S first visit and that test-negative
individuals will be told they
are uninfected and counseled
to help them maintain that
status. We also assumed that
individuals who test positive will be told they are "likely
infected," counseled appropriately, and asked to return for the
confirmatoryWB results. In an evaluation ofrapid test proce-
dures, Kassler et al8. found this approach to be acceptable to
both counselors and clients. Phrases such as "likely infected,"
"good chance of being infected," and "usually infected" were
used to communicate the probability of infection.
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Important policy issues arise from the type ofcounseling
these "likely infected" individuals receive at the initial visit
and the value placed on this information. Since some "likely
infected" individuals will not return for the confirmatory
WB results, the information they receive at the first visit is
critical. For our model, we valued information and counsel-
ing provided at the first visit for infected individuals who do
not return for confirmatory results as almost equivalent to
receiving the confirmatory information and assigned such
individuals a value of 0.99. Because this assumption may be
controversial, we performed a sensitivity analysis on the out-
come value. The outcomes for all uninfected individuals
who are told they are "likely infected" were assigned zero
values since incorrect information was provided.
Model Probabilities. The decision model underlying our
cost-effectiveness analysis is shown in Figure 1 for the cur-
rent C/T procedure and Figure 2 for the rapid C/T proce-
dure. Model probabilities and data sources are presented in
Table 2.
We assumed that the proportion of HIV-infected indi-
viduals in the population tested under each procedure was
0.04 (first chance node)9. The second chance node was the
probability of an individual accepting pretest counseling
which may depend upon an individual's serostatus as well as
the type of test procedure1'1°. We assumed in the basic
analysis that all individuals agree to be tested regardless of
serostatus or type of test.
The accuracy of the HIV antibody test and test algorithm
was the next factor. Under the current test procedure (three
ELISAs and one WB performed on the same specimen),
there is a four-test algorithm with (++++) or (+-++) or (++-+)
indicating positive results12. We assumed a three-test algo-
rithm under the rapid C/T procedure
(two rapid tests and oneWB on the same
specimen), with (+++) or (+-+) indicating
Return positive results. All other combinations
No were considered negative results.
return No consensus exists on a standard
algorithm for the rapid test. With theJ..{-IRetum current C/T procedure, initially reactive
No ELISAs are repeated twice to minimize
return the possibility of random error in batch
processing. In the rapid test algorithm,
where specimens can be run singly or in
batch, the likelihood of random error
m | introduced by splashing or specimen
mIx-up is reduced.
No We assumed the sensitivity and speci-
return ficity of the initial ELISA test to be
Return 0.9982. Negative results on the first
ELISA test receive no further attention.
No Blood samples that are reactive under
return I the initial ELISA test undergo the four-
test sequence. Based on calculations
from George and Schochetman , which
are available from the corresponding author, the probability
of a false negative is 0.00025 and the probability of a false
positive is 0.000000772 after the four-test algorithm, given
Table 2. Decision model probabilities
Varible Value Reference
Current C/T procedure:
HIVseroprevalence.........................................
HIV-infected client accepts
current test.....................................................
Uninfected client accepts current
test...................................................................
Test HIV+, given HIV+, I st ELISA...............
Test HIV+, given HIV-, I st ELISA ................
Test HIV+, given HIV+, 4-test series..........
Test HIV+, given HIV-, 4-test series...........
HIV-infected client returns for results........
Uninfected client returns for results...........
Rapid C/T procedure:
HIV seroprevalence.........................................
HIV-infected client accepts rapid test.........
Uninfected client accepts rapid test............
Test likely HIV+, given HIV+, rapid test....
Test likely HIV+, given HIV-, rapid test......
Test HIV+, given HIV+, 3-test series..........
Test HIV+, given HIV-, 3-test series...........
HIV-infected client returns for results........
Uninfected client (who tests positive)
returns for results.........................................
'Baseline assumption.
2Calculated from 2.
0.04 9
1.00
1.00
0.998
0.002
1.00
0.00
0.60
0.40
0.04
1.00
1.00
0.993
0.005
1.00
0.00
0.80
2
2
2
2
1,4,13
1,4,13
9
2
2
2
2
0.80
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a 0.04 proportion of HIV-infected individuals in the popu-
lation. Thus, the four-test sequence is a perfect test for all
practical purposes.
We assumed the sensitivity of the initial rapid test to be
0.993 and the specificity, 0.9952. The three-test algorithm
makes the rapid test sequence essentially a perfect test given a
proportion of HIV-infected individuals of 0.04. For the three-
test algorithm, the probability of a false negative is 0.000457
and the probability of a false positive is 0.000485.
The seronegative window
period between the time of
HIV acquisition and serocon-
version would not differ _
between the current and rapid
C/T procedures and was not
considered in this analysis.
Clients with high-risk behavior
who test negative would be
counseled about the need for
both behavior change and ii S
future testing5.
The final chance node for i '
both the current and rapid -
C/T procedures is the proba-
bility of a client returning for
the test result. All individuals
are asked to return under the
current C/T procedure, while
only those who test positive
with the rapid screening test
are asked to return for confir-
matory results under the rapid C/T procedure. The proba-
bility of returning for posttest counseling varies depending
on many factors including an individual's expected HIV
serostatus, risk exposure category or demographics, the type
of delivery site, and the reason for an initial visit4. In a 1990
study of publicly funded C/T sites, 82% of infected individ-
uals and 63% of uninfected individuals returned for posttest
counseling4. Results from the 1990 National Health Inter-
view Survey indicate that 53% of those at increased risk who
had a voluntary HIV-antibody test received posttest coun-
seling in contrast to 28% of those not at increased risk'3. For
this model, we assumed that 60% of infected individuals
return to obtain their test results under the current proce-
dure while 40% of those not infected return. The compara-
ble figures for those who are asked to return under the rapid
C/T procedure are assumed to be 80% for both infected and
uninfected (but diagnosed "likely positive") individuals.
Input Costs. Table 3 shows the input costs incorporated
into the model and their sources for both procedures. Since
the costs were measured from the perspective of adding
HIV counseling and testing services to an existing health
care facility, only the incremental costs were considered.
None of the fixed costs of the facility were included. All cost
variables were subdivided into price and quantity compo-
nents so the effect of each of these variables could be judged
independently. The value of clients' time-for counseling
and testing sessions and for return visits-was imputed by
using data on the median earnings of all workers'4. Costs
were measured in 1992 dollars'4"5.
We calculated costs for HIV-infected and uninfected
individuals under both test sequences. For an HIV-infected
individual under the current C/T procedure, the figure for
the first visit included administrative costs, the cost of
pretest counseling, and the
costs of three ELISA tests and
a Western blot test. The cost
*C figure for the return visit was
based on the client's time,
administrative costs, and the
cost of posttest counseling. An
uninfected individual incurs
the same administrative and
pretest counseling costs on the
6E i1iX3 initial visit but only one
ELISA test. He or she also
receives shorter posttest coun-
seling on the return visit.
With the rapid C/T proce-
i!6Xi dure, the cost figure for an
uninfected individual reflected
administrative and pretest
counseling costs on the first
visit, the cost of the rapid test,
the cost to the client of wait-
ing time at the clinic, and the
cost of posttest counseling at that visit. For the individual
who screened positive, the total figure included the same
administrative and pretest counseling costs, the costs of two
rapid tests, a longer waiting time, a more extensive posttest
counseling session at that visit, and a confirmatory VWB. The
costs for the return visit for this "likely infected" individual
were assumed to be the same as for the infected individual
under the current C/T procedure, whether or not the WB is
reactive. With the rapid C/T procedure, all of these individ-
uals would have been told they were "likely infected" at the
initial session and would require the longer posttest counsel-
ing at the return visit.
Since we disaggregated our costs into price and quantity
variables and imputed values for client waiting and travel
time, our overall cost measures are not directly comparable
to many of the estimates in the literature'6128. However, our
calculated results for specific tests (Table 3) are similar to
those in the literature620232529. Only a few studies of the
costs of HIV prevention interventions have incorporated
original data collection based on provider surveys and time
diaries28'29. Therefore, all cost variables in our models were
subject to sensitivity analysis.
Variations of the Basic Analysis. The basic analysis of the
decision model incorporated all costs measured from the
January/February 1 996 * Volume I I I
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societal perspective. Variation One was the basic analysis
excluding valuation of client time. Variation Two was the
basic analysis with the exception that we valued the out-
come for the HIV-infected individual who tests positive
under the rapid test but does not return for confirmatory
results at zero rather than 0.99.
Results
The total cost under the current HIV C/T procedure
was $103 for an infected individual and $33 for an unin-
fected individual, each of whom was correctly informed of
his/her serostatus and received posttest counseling (Table
3). For the rapid C/T procedure, the total cost for correct
information and counseling was $135 for an infected indi-
vidual and $33 for an uninfected individual. In both cases,
the costs are lower for uninfected clients due to fewer tests
and shorter counseling sessions. In addition, the rapid C/T
procedure eliminates the need for return visits for unin-
fected individuals, further reducing costs.
For the cost-effectiveness analysis, we adjusted these
cost figures for the fact that not all individuals will agree to
be tested or will return for test results. The adjusted or
"expected cost" was derived by multiplying the cost figure
based on frill participation (as presented above) by the prob-
abilities of an individual completing the various steps of the
Table 3. Decision model cost variables
Current procedure Rapid procedure
Positve
Vanable Value Reference
Negative Positive Negative
Value Reference Value Reference Value Reference
Total cost............................................................................................
Counseling, testing, first visit.........................................................
Wage rate, administrative processing (per hour)..............
Time, administrative processing (fraction of hour)...........
Wage rate, counselor, pretest (per hour)...........................
Time, pretest counseling (fraction of hour)........................
Value of client time, pretest (per hour)...............................
Value of client time, waiting (per hour) ...............................
Time,waiting (fraction of hour).............................................
Wage rate, administrative, laboratory work,
ELISA or Rapid test (per hour)...........................................
Time, administrative, laboratory work,
ELISA or Rapid test (fraction of hour)..............................
Costof materials, ELISA or Rapid test.................................
Wage rate, counselor, posttest (per hour).........................
Time, posttest counseling (fraction of hour) ......................
Value of client time, posttest (per hour).............................
Wage rate, administrative, laboratory work,
Western blot (per hour)......................................................
Time, administrative, laboratory work,
Western blot (per hour)..........................................................
Costof materials, Western blot............................................
Costof counseling, return visit.....................................................
Value of client time, return (per hour).................................
Time,client return (fraction of hour)...................................
Wage rate, administrative processing (per hour)..............
Time, administrative processing (fraction of hour)...........
Wage rate, counselor, posttest (per hour).........................
Time,posttest counseling (per hour) ...................................
Value of client time, posttest (per hour).............................
$103
72
8
0.25
$14
0.50
$10
-$33
20
14 8 14
2 0.25 2
14 14 14
28,29 0.50 28,29
14 10 14
$135
104
8
0.25
14
0.50
10
... ... ... ... ...
... ... ... ... 1.50
$15 14,15 Is 14,15 15
0.33
$1
2 0.33
29 1
$33
... ...
14 8 14
2 0.25 2
14 14 14
28,29 0.50 28,29
14 10 14
... 10
2 0.75
14
14,15 15 14,15
2 0.10 2 0.10
29 4 2,2 4 2,2
... ... ... ... 14 14 14 14
... ... ... ... 1 2 0.25 2
... ... ... ... 10 14 10 14
I5 14,15
25
31
10
0.50
$8
0.25
$14
... ... Is 14,15
2 22... ... 1
16,20,23,29 ... ... 25 16,20,23,29
13 31
14
2
14
2
14
5,29
10
0.50
8
0.25
14
0.25
14
2
14
2
14
5,29
10
0.50
8
0.25
14
14
2
14
2
14
2
10 14 10 14 10 14
'Calculated value.
2Baseline assumption.
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process. To derive cost-effectiveness ratios, these expected
costs were divided by the expected effects, i.e., the number
of individuals receiving correct test results and counseling.
The latter is also affected by the probabilities of an individ-
ual completing the various steps of the process.
Cost-effectiveness results for the basic analysis are pre-
sented in Table 4 for Outcome I, for which we included
only HIV-infected individuals who correctly learn their
serostatus, and Outcome II, for which we counted correctly
informed infected and uninfected individuals. The cost-
effectiveness ratios are incremental ratios comparing each
C/T procedure with a no-testing situation.
For Outcome I, the expected costs were $28 for the cur-
rent C/T procedure and $37 for the rapid C/T procedure.
The expected effect was 0.024 clients for the current proce-
dure and 0.040 for the rapid procedure. Dividing the
expected cost by the expected effect, we obtained a cost-
effectiveness ratio for the current procedure of $1165 per
HIV-infected client correctly counseled and tested and a
ratio of $940 for the rapid procedure. Thus, the cost per
HIV-infected client correctly counseled and tested was less
for the rapid procedure than for the current procedure. For
Outcome II, the expected costs were the same, but the
Table 4. Decision model results
Model Costs Effects Costeffects
Basic analysis'
Outcome I (HIV-infected only):
Current C/T procedure.................
Rapid C/T procedure.....................
Outcome 11 (HIV-infected and uninfec
Current C/T procedure.................
Rapid C/T procedure.....................
Outcome I (HIV-infected only):
Current C/T procedure.................
Rapid C/T procedure.....................
Outcome 11 (HIV-infected and uninfec
Current C/T procedure.................
Rapid C/T procedure.....................
Outcome I (HIV-infected only):
Current C/T procedure.................
Rapid C/T procedure.....................
Outcome 11 (HIV-infected and uninfec
Current C/T procedure.................
Rapid C/T procedure.....................
'Societal costs; Outcome value of 0.99 for a
returning, rapid C/T client.
2Provider costs; Outcome value of 0.99 for
returning, rapid C/T client.
'Societal costs; Outcome value of 0.00 for a
returning, rapid C/T client.
$27.91
37.27
ted):
27.91
0.0240 $1,165.26
0.0396 940.07
expected effects were 0.408 for the current procedure and
0.999 for rapid procedure. The cost-effectiveness ratios ($68
versus $37 per client informed, regardless of serostatus)
again favored the rapid C/T procedure.
Variation One, which included provider costs only, gave
an expected cost of $20 for the current C/T procedure and
$21 for the rapid C/T procedure. Since the effects were the
same as in the basic analysis, the cost-effectiveness ratios
favored the rapid C/T procedure ($821 versus $531 for
Outcome I; $48 versus $21 for Outcome II).
In Variation Two, for which we assigned a value of zero
to infected individuals who are told they are "likely infected"
after the rapid screening test but who do not return for con-
firmatory test results, the cost-effectiveness ratios favored
the current C/T procedure for Outcome I, which counted
only the HIV-infected ($1165 for the current procedure
versus $1172 for the rapid procedure). The ratios favored
the rapid procedure for Outcome II.
For the basic analysis, we performed sensitivity analyses
on all variables except the proportion of HIV-infected indi-
viduals and those measuring the accuracy of the tests. Table
5 presents the variables that caused the cost-effectiveness
ratio of the rapid C/T procedure to equal that of the current
C/T procedure (breakeven). The table compares the basic
analysis values of these variables with the break-even values.
The cost-effectiveness ratios were most sensitive to client
return rates and pre- and posttest counseling times.
With the given sensitivity and specificity of the tests,
the results regarding the accuracy of the four- and three-test
algorithms hold for proportions ofHIV-infected individuals
ranging from 0.01 to 0.10.
Discussion
0.4080 68.42
37.27 0.9987 37.31 Policy Issues. Our analysis shows that the rapid HIV coun-
Variation one2 seling and testing procedure is generally a more cost-effective
alternative to the current procedure for publicly funded clin-
ics, whether costs are measured from the societal or provider19.67 0.0240 821.25 perspectave. This result is particularly robust if the goal of the
21.0 00HIV counseling and testing process is to have both infected
:ted): and uninfected individuals correctly learn their serostatus
19.67 0.4080 48.22 (Outcome II). If the goal is to target HIV-infected individu-
21.06 0.9987 21.09 als (Outcome I), the rapid C/TI procedure is more cost-effec-
Variation two3 tive, only when the information received by infected individu-
als from the rapid test alone is seen as almost as valuable as
27.91 0.0240 $1,165.26 that provided through Western blot confirmation.
37.27 0.0318 1,172.74 This latter result raises an important policy issue. Under
:ted)- the current C/T procedure, no information is provided to a
27.91 0.4080 6842 client at the first visit based on the ELISA screening test
37.27 0.9908 37.61 alone. We assumed that for the rapid C/T procedure allindividuals who test negative will be told they are unin-
an infected, "likely-positive," non- fected at the first visit. This is a major factor influencing the
cost-effectiveness of the rapid procedure. Many of these
*aninfected,"likely-positive,"non- individuals might not have returned for their test results
an infected, "lkunder the current C/T procedure and would, therefore, notn Infected, "likely-positive." non- have received this information.
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Table S. Sensitivity analysis: basic analysis
Variable Bask valie
Break-ee Pecee dc e
value from bask value
Outcome I (HIV-infected only)
Model probabilities:
HIV+ client returns for
results, current test......... 0.60
HIV- client accepts
current test.................... 1.00
HIV+ client accepts
rapid test.................... 1.00
Current C/T procedure:
Wage rate, counselor,
pretest (hourly)................ $14.00
Time, pretest counseling
(fraction of hour)............. 0.50
Rapid C/T procedure:
Wage rate, administrative
processing (hourly) .......... $8.00
Time, administrative processing
(fraction of hour) ............. 0.25
Wage rate, counselor,
pretest (hourly) ................ $ 14.00
Time, pretest counseling
(fraction of hour) ............. 0.50
Value of client time,
pretest (hourly) ................$ 10.00
Wage rate, administrative,
laboratory work, rapid
test (hourly)................. $15.00
Time, administrative,
laboratory work, rapid
test (fraction of hour) ..... 0.10
Cost of materials,
rapid test................. $ 4.00
Value of client time,
waiting time (hourly).......$10.00
Time, waiting for results,
HIV- client
(fraction of hour) ............. 0.75
Wage rate, counselor,
posttest (hourly) ..............$14.00
Time, posttest counseling,
HIV- client, first visit
(fraction of hour) ............. 0.25
Value of client time,
posttest (hourly) .............. $ 10.00
Time, waiting for results,
likely HIV+ client
(fraction of hour) ............. 1.50
Time, posttest counseling,
HIV+ client, first visit
(fraction of hour) .............. 1.00
0.75
0.50
0.78
$3.20
0.27
$43.70
+ 25
- so
- 22
- 77
- 46
+ 446
1.40 + 460
$31.90
0.88
$ 27.90
$100.40
0.67
$12.60
$21.40
+ 128
+ 76
+ 179
+ 569
+ 570
+ 215
+ 114
1.69 + 125
$45.50
0.64
$41.50
+ 225
+ 156
+ 315
21.60 + 1,340
9.40 + 840
HIVTesting
Break-even Percent change
Varobk Basic vale value from basic value
Outcome 11 (HIV-infected and uninfected)
Model probabilities:
HIV- client returns for
results, current test......... 0.40
HIV- client accepts
rapid test.................... 1.00
Rapid C/T procedure:
Wage rate, administrative
processing (hourly) .......... $8.00
Time, administrative
processing
(fraction of hour) ............. 0.25
Wage rate, counselor,
pretest (hourly)................$ 14.00
Time, pretest counseling
(fraction of hour) ............. 0.50
Value of client dme,
pretest (hourly) ................ Sl°°00
Wage rate, administrative,
laboratory work, rapid
test (hourly).................... $15.00
Time, administrative,
laboratory work, rapid
test (fraction of hour) ..... 0.10
Cost of materials, rapid
test.................... $4.00
Value of client time,
waidng time (hourly).......$ 10.00.
Time waidng for results,
HIV- client
(fraction of hour) ............. 0.75
Wage rate, counselor,
posttest counseling
(hourly).................... $ S14.00
Time, posttest counseling,
HIV-client, first visit
(hourly).................... $ 0.25
Value of client time,
posttest counseling
(hourly).................... $ 10.00
Time, waidng for results,
likely HIV+ client
(fraction of hour) ............. 1.50
Time, posttest counseling,
likely HIV+ client
(fraction of hour)............. 1.00
0.95
0.34
+ 138
- 66
$132.20 + 1,553
4.20 + 1,580
$76.10
1.80
$ 72.10
+ 444
+ 260
+ 621
$312.40 + 1,983
2.09 + 1,990
$33.80
$49.70
4.00
$123.60
$1.60
+ 745
+ 397
+ 433
+ 783
+ 540
$119.60 + 1,096
71.30
0.10
+ 4,653
+ 2,910
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We also assumed that individuals who test positive with
the rapid test will be given this information at the initial
visit and asked to return for the results of the confirmatory
WB test. If decision makers believe that the information
from the rapid screening test should not be given to clients
because of concerns over possible false positives and that
counseling and testing should be targeted to infected indi-
viduals only, there is no advantage from a cost-effectiveness
perspective of using the rapid test. An ELISA screening test
would be equally cost-effective if no test results are given
out until the return visit.
Sensitivity Analysis: Outcome I. The sensitivity analysis
indicates several parameter changes that could increase the
cost- effectiveness of the current C/T procedure (Table 5).
Other factors constant, an increase in the return rate of25%
for HIV-infected individuals under the current C/T proce-
dure or a decrease in the number of uninfected individuals
who are tested by 50% would make the current CiT proce-
dure appear more cost-effective if the policy focus is on only
HIV-infected individuals (Outcome I). However, if addi-
tional outreach costs are incurred to increase the return rate,
this favorable effect would be diminished.
If the pretest counseling time is only one-quarter hour
under the current C/T procedure, which may have a nega-
tive effect on client return rates4, the current C/IT procedure
would be as cost-effective as the rapid procedure. A short
pretest counseling session may lower return rates since indi-
viduals may not have the time to personalize the risk of
HIV infection and may thus feel less compelled to return
and learn their test results4.
Only one other current C/T procedure variable, the
pretest counselor's wage rate, can be varied sufficiently to
make the two tests equivalent with respect to the cost-effec-
tiveness ratios for Outcome I. This variable would have to
decrease by 77%, all else constant, to reach the break-even
cost-effectiveness ratio.
For the rapid C/T procedure, an increase in pretest
counseling time from 0.5 to 0.88 hours, all else constant,
would increase the expected cost sufficiently to breakeven
with the current procedure. An increase in either posttest
counseling time for uninfected individuals from 0.25 to 0.64
hours or in waiting time at the initial session for these indi-
viduals from 0.75 to 1.69 hours would also make the cost-
effectiveness ratio of the rapid procedure equal to that of the
current procedure under Outcome I.
SensitivityAnalysis: Outcome II. If the goal ofHIV coun-
seling and testing is to have both HIV-infected and unin-
fected individuals correctly learn their serostatus, the return
rate of uninfected individuals has the greatest impact on the
evaluation of the two procedures. An increase in the proba-
bility of an uninfected individual returning for test results
from 0.40 to 0.95 under the current C/T procedure or a
decrease in the likelihood of an uninfected individual
accepting the rapid C/T procedure from 1.00 to 0.34, all
else held constant, would make the two cost-effectiveness
ratios equal. The rapid C/T procedure is generally more
cost-effective since uninfected individuals who would not
return to learn their test results under the current C/T pro-
cedure are more likely to receive information on their initial
visit under the rapid C/T procedure.
We found that no changes in the cost parameters for the
current C/T procedure could decrease the costs sufficiently
to make the cost-effectiveness ratio for the current CIT
procedure equal to that for the rapid C/T procedure when
the number of correctly informed HIV-infected and unin-
fected individuals is the outcome measure.
The sensitivity analysis results for the rapid C/T proce-
dure variables are extremely robust. Increases in the values
of these variables by 260% to over 4600% would be needed
to make the cost-effectiveness ratio of the rapid C/T proce-
dure equal to that for the current C/T procedure (Table 5).
Changes in the quantity variables also have much less
impact under Outcome II than under Outcome I. Pretest
counseling time would have to increase from 0.5 to 1.8
hours or waiting time at the initial visit for the uninfected
individual would have to increase from 0.75 to 4.00 hours to
reach the break-even point between the two testing
procedures.
Limitations. Our study does not deal with confidentiality or
other ethical issues surrounding HIV counseling and testing30
or with measuring the quality of the counseling sessions'.
Studies have shown that actual counseling sessions may devi-
ate from CDC recommendations for effective counseling3'5.
In addition, this study does not look at long-term impacts on
behavior ofHIV C/T, which should not differ under the two
procedures examined here. The precise long-term effects of
HIV counseling and testing appear to vary by population and
warrant further study9'3132. Such concerns must be weighed
carefully in addition to the results of this analysis when
choosing between the two testing procedures.
This study has been designed to compare each testing
procedure to a no-testing situation. What are the considera-
tions for a clinic already performing the current test? The
incremental cost-effectiveness ratio of the rapid versus the
current procedure is needed for that analysis. We calculated
the ratio to be $596 for the basic analysis counting HIV-
infected individuals only (Outcome I). The rapid test has
both higher expected costs and greater expected output than
the current test. Similar ratios can be calculated from Table 4.
This study was designed to be applicable to publicly
funded clinics and test sites. Other research suggests that a
large number of persons undergo HIV testing in private set-
tings5. Although few studies have been done of private sec-
tor testing, there is evidence that clients are less likely to
receive pre- and posttest counseling and that counseling
may be of lower quality in these settings5. Thus, comparing
the costs and effects of the current CIT procedure with the
rapid C/T procedure in private settings remains an issue for
future study.
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Summary and Conclusions
How individuals obtain accurate knowledge of their
HIV serostatus is an important policy issue, particularly
given the problem oflow return rates under the current C/T
procedure. This issue will become even more complex with
the development of new testing mechanisms such as home
testing kits30,33. Our cost-effectiveness analysis of the cur-
rent and rapid C/T procedures shows how different views of
the value attached to information provided at various stages
of the C/T process can affect the comparison of the proce-
dures. Our results suggest a need for a re-examination ofthe
current counseling and testing procedure as protocols are
developed for the new tests entering the market.
This analysis has also emphasized that the choice
between providing HIV counseling and testing for all indi-
viduals or for infected persons only can have an impact on
the cost-effectiveness of the different procedures. We have
shown how changes in the length ofC/T sessions can affect
cost-effectiveness ratios and may have an impact on other
significant variables such as return rates. Decision makers
must carefully weigh their own positions on these issues to
make an informed choice among the available C/T options.
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